Acura Pharmaceuticals Inc. (ACUR)
$4.49
-0.20 (-4.26%)
| CAPS Rating |
|
|---|---|
| Open | $4.59 |
| Previous Close | $4.69 |
| Daily Range | $4.49 - $4.77 |
| 52-Week Range | $4.00 - $9.00 |
| Market Cap | $192.93M |
| P/E Ratio | 44.85 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 6,744 |
| Average Daily Volume | 16,000 |
How do you think ACUR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ACUR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ACUR News and Commentary
- Fearful Stocks for Greedy Investors – The Motley Fool
- Seeking Gain From Pain – The Motley Fool
- A 1-in-100 Investor – The Motley Fool
- 10 Stocks Under Attack – The Motley Fool
- King Triples Down – The Motley Fool
Related News and Articles
- A Mostly Meaningless FDA Approval – The Motley Fool
- Biotech Bargains for Your Portfolio – The Motley Fool
- 7 of the Most Efficient Companies on the Planet – The Motley Fool
- 5-Star Stocks Poised to Pop: Diageo – The Motley Fool
- 3 China Profit Plays – The Motley Fool
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool


RSS Headlines
Fool UK